On this week’s episode, Mike and Jeremy talk to Dr. Merit Cudkowicz, chief of neurology at Massachusetts General Hospital and director of the Sean M. Healey & AMG Center for ALS, about the impact of COVID-19 on conducting clinical trials. Dr. Cudkowicz also provides an update on the Healey Platform Trial and potential long-term changes to trial design.

To learn more about Dr. Cudkowicz, go to https://www.massgeneral.org/doctors/16904/merit-cudkowicz

Read all about the Healey Platform Trial at https://alsadotorg.wordpress.com/2020/01/17/in-case-you-missed-it-the-als-association-invests-3-million-in-first-ever-als-platform-trial-to-speed-up-clinical-trial-process/

This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter.